Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

Keytruda

What is Keytruda (Keytruda®)?

Keytruda, pembrolizumabis a prescription medicine, an innovative breakthrough drug, humanized monoclonal antibody.

Keytruda belongs to the “immunotherapy” drugs that help the immune system attack the tumor. This contrasts, for example, with chemotherapy that directly affects tumor cells.

Keytruda and immunotherapy is therapeutic strategy has revolutionized the treatment of cancer in recent years and is one of the most studied strategies in the world for many types of cancer and different stages of treatments.

What is Keytruda used for?

Keytruda is prescribed by an oncologist and is used to treat various types of cancer, for example:

Advanced melanoma skin cancer when the disease has spread or cannot be removed by surgery.

Advanced non small cell lung cancerNSCLC, for patients with positive for PDL1 and not received chemotherapy and the tumor express EGFR or ALK gene/mutation.

Other cases can be for patients who received platinum chemotherapy and it is no longer working and the patients tumor express EGFR or ALK gene/mutation.

Other cases can be patients that also received an EGFR or ALK inhibitor medicine and it did not work any more.

Advanced head and neck squamous cells cancerHNSCC. if the disease has returned or spread and previous platinum chemotherapy  is no longer working.

Hodgkin lymphomacHL, in adults and children if the disease has returned and if the patients received 3 or more types of treatment.

Bladder and urinary tract cancer, urothelial carcinoma – for  metastatic disease or patients who can not receive cisplatin, or cases of a disease that progresses during chemotherapy treatment.

Cancer types among adults and children that is shown by a laboratory test to be a microsatellite instability high (MSI-H), or a mismatch repair deficient (dMMR) solid tumor.

Here there are a few points to consider, for example the cancer has spread or cannot be removed by surgery and there are no other satisfactory treatment options, or advanced colorectal cancer although a chemotherapy treatment

Advanced stomach cancer or gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma that tests positive for PDL1  if  chemotherapy did not work and the tumor has an abnormal HER2/neu gene/mutation, and the patient received a HER2/neu-targeted medicine.

What is it important to notice?

Ask your Oncologist how to use Keytruda if you are not sure.

The dosage and duration of Keytruda treatment will be determined by the doctor only.

Read the patient leaflet guide which is enclosed to each package.

Keytruda side effects- Read more >>

We wish you full health!

All rights reserved to Merck Sharp & Dohme Corp., New-Jersey, USA.

To Read More>>

To get a personal free assessment to our service please in fill in your details and we will get back to you shortly

Improve therapeutic outcomes, prolong life and quality of life are our main business. We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics

Close Menu